| HOME >> MEDICINE >> TECHNOLOGY |
Deferred rent 124,462 124,462
Deferred revenue 1,857,136 1,857,136
--------------------------
Total current liabilities 11,083,924 10,936,045
DEFERRED RENT 111,164 204,256
NON CURRENT PORTION OF CAPITAL LEASE OBLIGATION - 41,641
DEFERRED REVENUE 4,333,257 5,726,131
LONG-TERM DEBT, net 17,899,100 -
--------------------------
Total liabilities 33,427,445 16,908,073
--------------------------
COMMITMENTS
STOCKHOLDERS' EQUITY
Common Stock, $0.001 par value, 100,000,000
shares authorized, 21,751,503 and 21,232,991
shares issued and outstanding at June 30, 2008
(unaudited) and September 30, 2007,
respectively 21,752 21,233
Warrants to purchase 116,183 shares of common stock
for $12.05 per share, with 66,390 exercisable
starting September 30, 2007, and 49,793 shares
exercisable starting March 28, 2008 (unaudited) 1,140,114 526,720
Additional paid-in capital 120,124,752 115,518,201
Accumulated other comprehensive (loss) income (12,664) 4,405
Accumulated deficit (96,471,638) (57,134,233)
--------------------------
Total stockholders' equity 24,802,316 58,936,326
--------------------------
TOTAL
'/>"/>
| SOURCE Pharmasset, Inc. Copyright©2008 PR Newswire. All rights reserved |